Prab: CSV import

2025-02-23T21:27:53Z

CSV import

← Older revision		Revision as of 21:27, 23 February 2025
Line 50:		Line 50:

	{{medicine-stub}}		{{medicine-stub}}
			== Rentiapril ==
			<gallery>
			File:Rentiapril.svg\|Rentiapril
			File:Rentiapril_3D_ball.png\|Rentiapril 3D ball
			</gallery>

Prab: CSV import

2024-03-22T11:24:14Z

CSV import

New page

'''Rentiapril''' is a hypothetical [[angiotensin-converting enzyme (ACE) inhibitor]] used in the management of [[hypertension]] and [[heart failure]]. Like other ACE inhibitors, Rentiapril functions by blocking the conversion of [[angiotensin I]] to [[angiotensin II]], a potent vasoconstrictor, thereby reducing blood pressure and alleviating the workload on the heart. This article provides a comprehensive overview of Rentiapril, including its mechanism of action, pharmacokinetics, clinical applications, adverse effects, and contraindications.

==Mechanism of Action==
Rentiapril inhibits the angiotensin-converting enzyme, which is responsible for the conversion of angiotensin I to angiotensin II. Angiotensin II is a powerful vasoconstrictor that also stimulates the release of [[aldosterone]] from the adrenal cortex, leading to water and sodium retention. By inhibiting the production of angiotensin II, Rentiapril decreases blood volume and vascular resistance, which in turn lowers blood pressure and reduces the heart's oxygen demand.

==Pharmacokinetics==
After oral administration, Rentiapril is rapidly absorbed from the gastrointestinal tract. It undergoes partial metabolism in the liver and is excreted primarily in the urine. The bioavailability of Rentiapril and its active metabolites contributes to its therapeutic effects. The onset of action typically occurs within one hour of administration, with peak effects observed within 4 to 6 hours. The duration of action for a single dose of Rentiapril can last up to 24 hours, making it suitable for once-daily dosing.

==Clinical Applications==
Rentiapril is indicated for the treatment of:
* [[Hypertension]] - to lower blood pressure and reduce the risk of cardiovascular events.
* [[Heart failure]] - to improve survival and reduce hospitalizations for patients with heart failure.
* [[Left ventricular dysfunction]] - to prevent the progression of heart failure in patients with asymptomatic ventricular dysfunction.

==Adverse Effects==
Common adverse effects of Rentiapril include:
* Cough
* Hyperkalemia
* Fatigue
* Dizziness
* Headache

Less common but more serious adverse effects may include:
* Angioedema
* Renal impairment
* Hypotension, especially after the first dose

Patients should be monitored for signs of angioedema and renal function should be assessed before and during treatment.

==Contraindications==
Rentiapril is contraindicated in patients with:
* A history of angioedema related to previous ACE inhibitor therapy
* Bilateral renal artery stenosis
* Hypersensitivity to Rentiapril or any component of the formulation

==Drug Interactions==
Rentiapril can interact with several other medications, including:
* [[Diuretics]] - may increase the risk of hypotension
* [[Potassium-sparing diuretics]] and [[potassium supplements]] - may increase the risk of hyperkalemia
* [[Nonsteroidal anti-inflammatory drugs (NSAIDs)]] - may reduce the antihypertensive effect of Rentiapril

Patients should inform their healthcare provider of all medications they are taking to avoid potential drug interactions.

==Conclusion==
Rentiapril is a valuable medication in the management of hypertension and heart failure. Its ability to inhibit the angiotensin-converting enzyme leads to reduced blood pressure and improved cardiac function. However, like all medications, it is associated with potential adverse effects and contraindications. Patients should be closely monitored to ensure the safe and effective use of Rentiapril.

[[Category:ACE inhibitors]]
[[Category:Antihypertensive drugs]]
[[Category:Cardiovascular system drug stubs]]

{{medicine-stub}}

Rentiapril - Revision history

Prab: CSV import

Prab: CSV import